High Court To Weigh In On Amgen Class Cert. Quarrel
The U.S. Supreme Court on Monday agreed to hear an appeal of a Ninth Circuit decision that kept intact a shareholder class alleging Amgen Inc. misled investors about the safety of...To view the full article, register now.
Already a subscriber? Click here to view full article